Cancer
-
April 29, 2021
Songs written by Palliative Care Unit caregivers reflect uncertain times and offer a reminder: “Take Good Care”
Five songs providing a snapshot of how the pandemic year felt on the patient care front lines -
April 22, 2021
Vanderbilt Wilson County Hospital President Hinesley departing VUMC to join MUSC
Julian “Jay” Hinesley III, MHA, President of Vanderbilt Wilson County Hospital (VWCH), is leaving his role with Vanderbilt University Medical Center to join the Medical University of South Carolina (MUSC) as Chief Executive Officer for MUSC Health’s Florence Division in Florence, South Carolina, where he will lead three hospitals located in Florence and adjacent communities. He will depart VWCH and VUMC on April 30. -
April 20, 2021
The inside story behind the Hillsboro Village “Hope” mural: a brother’s love and a message for Children’s Hospital
Lance Gregory wanted the message to be visible from the windows of Children's Hospital — in memory of his brother Cory -
April 20, 2021
New therapeutic strategy for leukemia syndrome
Using primary cells from patients with chronic myelomonocytic leukemia, Vanderbilt researchers found synergistic inhibition of cell viability and proliferation, suggesting a new treatment strategy. -
April 16, 2021
New Clinician Spotlight: Laura Kennedy
Laura Kennedy, MD, PhD, has joined Vanderbilt University Medical Center from the University of Washington School of Medicine/Fred Hutchinson Cancer Research Center in Seattle where she was acting instructor and research associate. -
April 15, 2021
Method proposed to correct misinterpretations of long-term survival rates for immunotherapies
Immune checkpoint inhibitors have transformed cancer care to the point where the popular Cox proportional-hazards model provides misleading estimates of the treatment effect, according to a new study published April 15 in JAMA Oncology. -
April 8, 2021
Personalized Structural Biology aids cancer treatment decisions
Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level.